Interestingly, the expression of TYK2 exhibited a stronger positive correlation with the expression of immune checkpoint genes, especially PDCD1 and TIGIT, in patients with HNSCC who were HPV-positive (Supplementary Figure S4). This evidence concerns the gene TYK2 and head and neck squamous cell carcinoma.